ArticleNeurosurgery2015

Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target.

Ray R Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.